Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...ions caused by AMR organisms. With drugs not listed on the essential drugs list (EDL), problems of increased morbidity, costs of extended hospitalisation and mortality are extremely serious. The problem of susceptibility to and spread of infections caused by multidrug-resistant (MDR) infectious agents is fuelled by factors such as limited access to clean water and sanitation to ensure personal hygiene, malnutrition, and the HIV/TB epidemic.
more
Mapping Report - Portugal
Access to controlled medicines. 3rd edition
1 July 2021; Report shows big COVID-19-related HIV prevention programme service disruptions, but highlights that HIV service innovations and adaptations are possible.
A synthesis report on programme disruptions and adaptations during the COVID-19 pandemic in 2020
(Health Systems in Transition, Vol. 4, No. 3, 2014)
Guidance on Implending Publi-Private Mix Approaches
World Drug Report 2018
-2-
Copenhagen, Denmark, 7–8 March 2017. Meeting report
Directions in Development
Human Development
Technical Update
HIV Treatment
July 2017
Germany has become a visible actor in global health in the past 10 years. In this Series paper, we describe how this development complements a broad change in perspective in German foreign policy.
This Guide responds to requests from practitioners and country teams who have learned about the Nurturing care framework and want to understand how to adapt health and nutrition services to be supportive of nurturing care and strengthen caregivers’ capacity.
Advocacy report March 2011
303100 03/2011 E 1,000
Principes directeurs à l’intention des programmes nationaux et autres partenaires